Knott David M Jr
Knott David M Jr
Assets Managed
$168.034M
Holdings
85
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
-22.18%(2Q avg: -17.55%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Knott David M Jr's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 85 positions.
Assets under management
The assets under management (AUM) of Knott David M Jr over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 168.034M in assets, with a quarterly growth rate of -22.18% and a 2-quarter average growth rate of -17.55%. The portfolio is managed by Knott David M Jr, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
GOOG Alphabet Inc-cl C
| 15.61% | $26.228M 91,420 shares@ $286.9 avg price | |
APO Apollo Global Management Inc
| 14.92% | $25.069M 225,000 shares@ $111.42 avg price | |
SNDX Syndax Pharmaceuticals Inc
| 5.87% | $9.858M 422,000 shares@ $23.36 avg price | Increased 1.69% |
BBIO Bridgebio Pharma Inc
| 3.98% | $6.683M 90,000 shares@ $74.26 avg price | Increased 5.89% |
PTGX Protagonist Therapeutics Inc
| 3.96% | $6.64M 63,000 shares@ $105.4 avg price | Decreased -13.69% |
XERS Xeris Biopharma Holdings Inc
| 3.66% | $6.148M 1.06M shares@ $5.8 avg price | Increased 9.28% |
JPM Jpmorgan Chase & Co
| 3.41% | $5.729M 19,477 shares@ $294.16 avg price | |
IOVA Iovance Biotherapeutics Inc
| 3.35% | $5.616M 1.6M shares@ $3.51 avg price | New Position |
ur-1⤦ Lpl Financial Holdings Inc.
| 2.96% | $4.964M 16,500 shares@ $300.83 avg price | New Position |
JAAA Janus Henderson Aaa Clo Etf
| 2.81% | $4.711M 93,528 shares@ $50.37 avg price |
1-10 of 85